How can and should cannabinoids be added to the analgesic formulary? Dr. Fine reviews the management of pain and types of pain and then explores the impact of cannabis on neuropathic pain through a review of clinical trials. A close look at the myriad of receptors in the brain involved in the perception or experience of pain reveals the potential for medical cannabis in this complex system.
Purchase of this medical cannabis education course grants one learner one year’s access to lessons and quizzes (access expires 365 days from date of course activation).
Perry G. Fine, MD
Dr. Fine is a Professor in the Department of Anesthesiology of the School of Medicine at the University of Utah, where he serves on the faculty in the Pain Research Center, and is an attending physician in the Pain Management Center. Dr. Fine is the National Strategic Advisor for Capital Hospice, Washington, DC developing sustainable models of advanced illness coordinated care in community settings, as an integrative component of comprehensive advanced illness care. He is Past President of the American Academy of Pain Medicine, and represents the Academy on the Steering Committee of the Pain Care Coalition, Washington, DC. He also serves on the Clinical Models Committee of the Coalition to Transform Advanced Care (C-TAC). He serves on the Board of Directors of ISA Scientific, developing new safe and effective analgesic therapies for the treatment of chronic pain.